Telix Pharmaceuticals Limited
TLX
$9.36
-$0.07-0.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 207.16M | 207.16M | 439.60M | 492.51M | 79.29M |
| Total Receivables | 123.63M | 123.63M | 92.51M | 103.64M | 59.60M |
| Inventory | 35.23M | 35.23M | 23.61M | 26.45M | 20.55M |
| Prepaid Expenses | -- | -- | 6.86M | 7.68M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 32.00M | 32.00M | 5.89M | 6.60M | 10.87M |
| Total Current Assets | 398.01M | 398.01M | 568.45M | 636.87M | 170.31M |
|
|
|||||
| Total Current Assets | 398.01M | 398.01M | 568.45M | 636.87M | 170.31M |
| Net Property, Plant & Equipment | 74.18M | 74.18M | 33.62M | 37.66M | 25.52M |
| Long-term Investments | 185.81M | 185.81M | 66.00M | 73.94M | 78.56M |
| Goodwill | 185.81M | 185.81M | 66.00M | 73.94M | 78.56M |
| Total Other Intangibles | 398.36M | 398.36M | 191.53M | 214.58M | 187.98M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 129.53M | 129.53M | 75.08M | 84.12M | 28.35M |
| Total Assets | 1.19B | 1.19B | 938.44M | 1.05B | 497.70M |
|
|
|||||
| Total Accounts Payable | 51.69M | 51.69M | 42.51M | 47.63M | 14.88M |
| Total Accrued Expenses | 59.09M | 59.09M | 47.89M | 53.65M | 46.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.06M | 21.06M | 13.30M | 14.90M | 2.52M |
| Total Finance Division Other Current Liabilities | 166.75M | 166.75M | 101.08M | 113.25M | 108.37M |
| Total Other Current Liabilities | 166.75M | 166.75M | 101.08M | 113.25M | 108.37M |
| Total Current Liabilities | 298.58M | 298.58M | 204.79M | 229.43M | 172.39M |
|
|
|||||
| Total Current Liabilities | 298.58M | 298.58M | 204.79M | 229.43M | 172.39M |
| Long-Term Debt | 371.48M | 371.48M | 341.49M | 382.60M | 6.64M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.71M | 25.71M | 5.04M | 5.64M | 5.61M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 72.24M | 72.24M | 35.49M | 39.76M | 43.53M |
| Total Liabilities | 768.01M | 768.01M | 586.80M | 657.43M | 228.17M |
|
|
|||||
| Common Stock & APIC | 473.11M | 473.11M | 369.31M | 413.77M | 391.92M |
| Retained Earnings | -150.98M | -150.98M | -131.79M | -147.65M | -155.79M |
| Treasury Stock & Other | 99.81M | 99.81M | 114.12M | 127.85M | 33.41M |
| Total Common Equity | 421.94M | 421.94M | 351.64M | 393.96M | 269.53M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 421.94M | 421.94M | 351.64M | 393.96M | 269.53M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 421.94M | 421.94M | 351.64M | 393.96M | 269.53M |
|
|
|||||